Our Pricing

Published on: June 03, 2026

Looking to buy Wegovy UK private prescription without the NHS waiting list? At Cured Pharmacy, you can access genuine UK-licensed Wegovy pens from £79.00, with a free online consultation completed in under 3 minutes by our UK-registered clinical team. No appointments, no delays—just transparent pricing and discreet next-day delivery across the UK.

Why Choose Private Prescription for Wegovy in the UK

NHS access to Wegovy remains severely restricted, with eligibility criteria limiting treatment to patients with a BMI of 35 or above (or 30 with weight-related complications) and capacity constraints meaning many eligible patients face months of waiting [1]. A private prescription through a registered UK online pharmacy like Cured allows you to bypass these delays entirely, subject to clinical assessment by our UK prescribers.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription dispensed from our GPhC-registered pharmacy (9012511), ensuring you receive the same pharmaceutical-grade Wegovy pens available through the NHS—just without the wait. All consultations are conducted by UK-registered prescribers who assess your medical history, current medications, and suitability for semaglutide treatment before approving your prescription.

How Wegovy Works: The Science Behind Semaglutide

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your gut produces after eating [2]. It works through three complementary mechanisms: slowing gastric emptying so you feel fuller for longer, reducing appetite signals in the brain, and improving insulin sensitivity to help regulate blood sugar levels.

In the landmark STEP 1 clinical trial involving 1,961 adults with obesity, participants using Wegovy achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [2]. Importantly, 86.4% of Wegovy users lost at least 5% of their body weight—a threshold associated with significant improvements in cardiovascular and metabolic health markers [2].

The medication is administered as a once-weekly subcutaneous injection, with doses gradually increased over 16-20 weeks from 0.25mg to the maintenance dose of 2.4mg. This titration schedule, carefully designed through clinical trials, minimises gastrointestinal side effects while optimising weight loss outcomes [3].

Expected Results and Timeline

Most patients begin noticing appetite suppression within the first 1-2 weeks of treatment, though visible weight loss typically becomes apparent after 4-8 weeks [2]. Clinical trial data shows the most significant weight reduction occurs between weeks 20 and 60, with weight stabilising thereafter when combined with lifestyle modifications [3]. Your UK prescriber will monitor your progress through follow-up consultations to ensure the treatment remains appropriate and effective for your individual circumstances.

Wegovy Dosing Schedule and What to Expect

Wegovy follows a structured dose escalation protocol designed to improve tolerability. You'll begin with 0.25mg once weekly for 4 weeks, then increase to 0.5mg for 4 weeks, followed by 1mg, 1.7mg, and finally the maintenance dose of 2.4mg [3]. Each pen is pre-filled and designed for single use, with the injection administered into your abdomen, thigh, or upper arm.

The most common side effects—nausea, diarrhoea, and constipation—are typically mild to moderate and diminish as your body adjusts to each dose level [3]. Approximately 5-10% of patients in clinical trials discontinued treatment due to gastrointestinal side effects, though these rates were significantly lower with proper dose titration [2]. If you experience persistent side effects, your prescriber may recommend staying at your current dose for an additional month before escalating.

Storage and Administration

Store unused Wegovy pens in the refrigerator between 2°C and 8°C, away from the freezer compartment. Once in use, pens can be kept at room temperature (below 30°C) for up to 28 days. The injection itself takes seconds—simply attach a new needle, dial your dose, and inject into clean skin at a 90-degree angle. Detailed instructions are provided with every prescription, and our clinical team is available on (+44) 116 4646009 if you have questions about administration technique.

Who Can Use Wegovy: Eligibility and Contraindications

Wegovy is licensed in the UK for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [1]. During your online consultation, our UK prescriber will calculate your BMI, review your medical history, and assess whether Wegovy is the most appropriate treatment option for your circumstances.

The medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), as animal studies showed thyroid C-cell tumours at high doses [3]. It's also not recommended during pregnancy or breastfeeding, or for individuals with severe gastrointestinal disease, diabetic retinopathy, or a history of pancreatitis without careful specialist oversight.

If you're currently taking other medications—particularly insulin, sulfonylureas, or other glucose-lowering treatments—your prescriber will assess potential interactions and may adjust your existing therapy to prevent hypoglycaemia [3]. Always disclose all current medications and supplements during your consultation to ensure safe prescribing.

Buy Wegovy UK: Your Private Prescription Journey at Cured Pharmacy

Getting started with Wegovy through Cured Pharmacy takes under 5 minutes. Click 'Start Assessment' to complete our secure online consultation form, which covers your medical history, current medications, weight loss goals, and any contraindications. A UK-registered prescriber reviews your submission, typically within 24 hours on weekdays, and approves your prescription if clinically appropriate.

Once approved, your Wegovy pens are dispensed from our GPhC-registered pharmacy and dispatched via tracked courier in 100% discreet packaging—no external branding or medication details visible. Most orders placed before 3pm Monday-Thursday arrive the next working day across mainland UK. You'll receive SMS and email tracking updates at every stage, and our clinical team remains available for follow-up questions throughout your treatment journey.

We offer transparent upfront pricing with no hidden consultation fees or subscription traps. You'll see the exact cost—from £79.00 for Wegovy—before completing your assessment, and you're never charged unless a prescriber approves your treatment. This is pharmaceutical care as it should be: accessible, affordable, and built around your needs.

Ongoing Support and Monitoring

Weight loss treatment isn't a one-off transaction—it requires ongoing clinical oversight. Our prescribers schedule follow-up consultations every 8-12 weeks to monitor your progress, assess tolerability, and adjust your treatment plan if needed. You can message our clinical team at any point through your secure patient portal, and we'll respond within one working day. This continuity of care ensures Wegovy remains safe and effective throughout your weight loss journey.

Wegovy vs Other Weight Loss Treatments: Making an Informed Choice

The UK market now offers several prescription weight loss medications, each with distinct mechanisms, dosing schedules, and clinical evidence. Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist delivering an average 14.9% body weight reduction in clinical trials [2]. Saxenda (liraglutide), an older GLP-1 agonist, requires daily injections and produces an average 8% weight loss over 56 weeks [4].

Oral options include Orlistat, a lipase inhibitor that blocks dietary fat absorption, producing modest 3-5% weight loss but with gastrointestinal side effects if high-fat foods are consumed [5]. Mysimba combines naltrexone and bupropion to reduce appetite and cravings, achieving approximately 5-9% weight reduction in clinical trials [6]. The choice between these depends on your medical history, BMI, tolerance for injections, and response to previous treatments.

Your UK prescriber will discuss these options during your consultation, considering factors like existing medications, lifestyle preferences, and weight loss targets. There's no single 'best' treatment—only the most appropriate one for your individual circumstances, prescribed under proper clinical oversight.

Scientific References

1. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines.org.uk. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
6. Greenway, F. L., Fujioka, K., Plodkowski, R. A., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595–605. https://doi.org/10.1016/S0140-6736(10)60888-4 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment and lifestyle modifications.